Common asthma drug cuts Covid-19 hospitalization, recovery time – Oxford study
reuters.com
reuters.com
https://www.medrxiv.org/content/10.1101/2021.02.04.21251134v...
Your point about news websites' disincentive to link outbound is taken, but plenty of journalists (most?) are freelancers. Probably it's the paper's editors who feel those incentives.
It may or may not solve the problem but has the potential to cut away some of the anxiety and trauma connected to not getting enough oxygen.
It is not a cure for asthma but a complementary technique. This means that people using Buteyko should still continue take their inhalers as prescribed however research has shown that inhaler use can significantly reduce over time.
From an evolutionary perspective, that's remarkable. Have you looked into the possibility that it's not your allergies, per se, but your microbiome that is the troublemaker?
Several members of my family have improved their asthma symptoms by cleaning up their diet, allowing them to get off medication.
I know many issues people have are genetic, but the amount caused by a poor or incompatible diet are incredible.
I just found a 1992 paper on some details of budesonide. If I understand it correctly, then budesonide has an effect on platelet aggregation of serotonin via the 5-HT2A receptor. (Which I haven’t learned to be common among steroids? But I’m a layman, so!)
The paper: Inhaled budesonide regimen enhances serotonin- and arachidonic acid-induced platelet aggregation – https://doi.org/10.1007/BF01991227
Platelet and serotonin interaction are intimately involved in inflammation and clotting. This interests me in connection with the randomized controlled trial study showing successful use of the SSRI fluvoxamine in managing severe COVID-19 cases, as defined by a measure of preventing clinical deterioration: https://doi.org/10.1001/jama.2020.22760
Also in relation with the quite sound-looking theory that the serotonin metabolism in the lung (a known aspect of the global serotonin mechanism) can be hit by the endothelial damage and inflammation in COVID-19, having the potential to cause a runaway feedback loop of inflammation and abnormal clotting. Platelets store serotonin, and serotonin is an immunomodulator, usually increasing inflammation in tissue, as well as usually causing veins and capillaries to contract. (As far as I understand things.) As yet unverified by a controlled trial, but there is a strong and clear theoretical basis and strong anecdotal indications. More info here: https://mobile.twitter.com/farid__jalali/status/133547064688...
Bad layman, bad!
CORRECTION: I must correct my lay hands’ pollution of the information on paper. The ‘92 study on budesonide makes an indicative argument towards action on the 5-HT2 receptor subtype. I mistakenly overspecified the 5-HT2A sub-subtype. I hope it isn’t grievously incorrect. There are three 5-HT2 receptor subtypes, A, B, and C: https://en.wikipedia.org/wiki/5-HT2_receptor – according to the individual Wikipedia entries, the 5-HT2A subtype is highly expressed on platelets, and the 5-HT2B is also expressed. No mention of platelets for the 5-HT2C subtype.
It is indeed true that psychedelics are generally known as agonists of the 5-HT2A receptor. Seemingly they tend to be agonists of the B and C subtypes as well, as per Wikipedia.
And interestingly enough, the substances known as psychedelics are also very significant and notable immunomodulators! As per this paper: Psychedelics and immunomodulation: novel approaches and therapeutic opportunities – A. Szabo, Frontiers of Immunology, 2015 – https://doi.org/10.3389/fimmu.2015.00358
(I want to mention author A. Szabo’s credentials: The 2015 paper cites the researcher’s position at Department of Immunology, Faculty of Medicine, University of Debrecen, Hungary. Subsequent publications show a position at the NORMENT Center of Excellence (CoE), Institute of Clinical Medicine, University of Oslo and the Department of Medical Genetics, both at Oslo University Hospital, Norway. Source: https://loop.frontiersin.org/people/193869/overview – There is reason to assume that this is a serious and capable person.)
There is mention of the Sigma-1 receptor as well in Szabo’s 2015 paper on immunomodulation. I want to take great care to not make spurious connections, but I did find this paper curious and interesting in this context: Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy? - J. M. Vela, Frontiers of Immunology, November 2020 – https://www.frontiersin.org/articles/10.3389/fphar.2020.5823...
Via: https://twitter.com/EricLenze2/status/1364459057629773824
It would also be curious to know if people who are already taking the steroids have possible benefits for Covid illness, or if its main benefit is if it started at the onset of illness.
Also, dexamethasone, a systemic steroid, seems to have comparable effects; likely, they both reduce or stop the damage from overactive immune response, which is likely a big part of covid complications.
For avoidance of doubt, this is the twist:
Inhaled budesonide regimen enhances serotonin- and arachidonic acid-induced platelet aggregation [via the 5-HT2A serotonin receptor?] – https://doi.org/10.1007/BF01991227
Edit: In the light of downvotes - which I receive with kindness and in good spirits - then - again purely for avoidance of doubt - I want to confirm that this is the message.
...just waiting for that result to be destroyed now. That said, the UK studies have been quite solid so far.
My doctor gave me a shotgun cocktail of prednisone (another glucocorticoid), Azitromicyn, Ivermectin, Ibuprofen and Aspirin. More likely I was one of the majority that don't develop grave symptoms, but maybe the Prednisone played a part, as Azitromicyn and Ivermectin are no longer recommended as treatment because their effect at normal doses is questionable.
https://en.wikipedia.org/wiki/Budesonide#Pharmacology
So one of the things it does is it impacts the circulatory system. Covid has significant impact on the blood and this fact seems to account for a lot of things that went badly sideways in ways that weren't readily understood. For example, ventilators were getting especially poor results, from which I infer that the respiratory element of the infection isn't the primary way it kills most people.
Steroids generally support immune function and are often prescribed alongside antibiotics for serious infections. They are hard on the body and getting off steroids is the hardest withdrawal experience I ever had out of the dozen or more medications I eventually got off of. I have been told by other people that, yup, getting off steroids is typically a real bitch (though there are things that can be done to mitigate it, which is how I eventually successfully got off of them).
In this study, primary outcome was a combination of: hospitalization, urgent care visit, or emergency room visit. There were 10 in the placebo and 1 in the budesonide group. But I can't find whether those events, or what proportion, were hospitalizations vs ER vs urgent care visits. If I'm missing something someone please correct me. To me it would not be a great therapeutic option if, for example and I'm making this up, the budesonide group had 1 hospitalization and the placebo had 10 urgent care visits.
Also the number of patients was ~146, would like to see much higher numbers to catch what's significant to me, which is percent hospitalization. If you read their methods they created the study under the assumption that "20% of COVID-19 patients would be severe", when it was designed back in March which is a bit high.
See how coverage of the same drug for a novel treatment was different pre covid:
https://www.ksat.com/news/2019/11/13/new-drug-delivery-relie...
Post covid:
https://www.ksat.com/news/local/2020/07/14/is-inhaled-steroi...
"X cures COVID 100% and the WHO is suppressing it to help Big Pharma!" will. (Might. Enforcement is spotty.)
Think about the thousands of humans with bias involved in those decisions one by one.
What about salmeterol + fluticasone?
I know the answers are not there in the article, but do you suppose that the results would be same / similar?
Guess I'll take this one upside over no upsides of having asthma. (I'm on Symbicort, which is basically part this and part formoterol).
Of these, ivermectin’s safety profile is “incredibly safe”, hcq “mostly safe with some caveats”; don’t remember about cholcocine or whatever it is called.
I am perplexed at the complete and utter avoidance from western countries (including US, Britain and Israel) of these.
Yes, vaccines are a better solution long term, and it is good to give them high priority. But there isn’t really a competition for resources here. I just can’t understand it.
Dexamethasone's effects were discovered by a study in the UK, and: "Changes in the NHS covid-19 treatment protocol were soon announced based on these results". My wife confirms this, she's a nurse.
https://www.bmj.com/content/370/bmj.m2648
Hydrochloroquine is not effective as a Covid-19 treatment: "However, available evidence does not support the use of this medication in the prevention or treatment of COVID-19."
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9...
As for ivermectin: "Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients."
Although they do recommend further studies. It seems it could be useful, but there are alternative treatments available now that are more effective.
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5...
Dexamethasone is a standard treatment in the UK in line with WHO guidance[1]. Its use was first recommended in June 2020, before the final analysis of the RECOVERY study results was even published[2]. I was treated with it in October 2016.
Hydroxychloroquine was trialed, and found not to be effective in hospitalised patients[3].
[1] https://www.england.nhs.uk/wp-content/uploads/2020/11/C0870_...
[2] https://www.gpni.co.uk/wp-content/uploads/2020/06/DEXAMETHAS...
[3] "On 5 June 2020, the trial determined that there was no clinical benefit from use of hydroxychloroquine in people hospitalized with COVID-19." https://en.wikipedia.org/wiki/RECOVERY_Trial#Hydroxychloroqu...
There's another site I cannot remember the domain of now, that aggregates as many studies as it can find. It claims something like 2/3 of studies show positive effects.
Edit: Found it, and it includes links at the top for similar sites on Ivermectin, Vitamin D, Zinc, etc - https://c19study.com/
Reddit.com/r/ivermectine
Zinc!, Vitamin C!, the other thing!
Clickbait shmickbait